These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31022157)

  • 1. Sulfonamide cross-reactivity.
    Med Lett Drugs Ther; 2019 Mar; 61(1568):44-46. PubMed ID: 31022157
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclooxygenase inhibitors and cardiovascular risk.
    Andersohn F; Suissa S; Garbe E
    JAMA; 2007 Feb; 297(6):586-7; author reply 587-8. PubMed ID: 17299191
    [No Abstract]   [Full Text] [Related]  

  • 3. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy.
    Knowles S; Shapiro L; Shear NH
    Drug Saf; 2001; 24(4):239-47. PubMed ID: 11330653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity?
    Wulf NR; Matuszewski KA
    Am J Health Syst Pharm; 2013 Sep; 70(17):1483-94. PubMed ID: 23943179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No proof of cross-reactivity between celecoxib and antibiotic sulfonamides.
    Smith WB; Mullins RJ
    Intern Med J; 2007 May; 37(5):347-8. PubMed ID: 17504291
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.
    Shapiro LE; Knowles SR; Weber E; Neuman MG; Shear NH
    Drug Saf; 2003; 26(3):187-95. PubMed ID: 12580647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugs.
    Lehmann DF
    Drug Metab Lett; 2012 Jun; 6(2):129-33. PubMed ID: 23157194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity.
    Li L; Laidlaw T
    J Allergy Clin Immunol Pract; 2019; 7(8):2891-2893.e4. PubMed ID: 31100553
    [No Abstract]   [Full Text] [Related]  

  • 9. [«Sulfonamide allergy» - which drugs must patients avoid?].
    Hagen NT; Spigset O
    Tidsskr Nor Laegeforen; 2016 Jun; 136(10):915-8. PubMed ID: 27272369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs.
    Cimbollek S; Quiralte J; Avila R
    N Engl J Med; 2009 Nov; 361(22):2197-8. PubMed ID: 19940308
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfonamide Drug Allergy.
    Dorn JM; Alpern M; McNulty C; Volcheck GW
    Curr Allergy Asthma Rep; 2018 Jun; 18(7):38. PubMed ID: 29876667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective cyclooxygenase-2 inhibitor hypersensitivity].
    Romero-Sánchez L; López-Freire S; González-Fernández T; Méndez-Brea P
    Rev Alerg Mex; 2023 Jan; 69(2):101-104. PubMed ID: 36928252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group.
    Brackett CC; Singh H; Block JH
    Pharmacotherapy; 2004 Jul; 24(7):856-70. PubMed ID: 15303450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.
    Strom BL; Schinnar R; Apter AJ; Margolis DJ; Lautenbach E; Hennessy S; Bilker WB; Pettitt D
    N Engl J Med; 2003 Oct; 349(17):1628-35. PubMed ID: 14573734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wynn RL
    Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
    [No Abstract]   [Full Text] [Related]  

  • 17. Are COX-2 inhibitors safe for anyone.
    Bloomfeld RS
    Inflamm Bowel Dis; 2006 Sep; 12(9):922-3. PubMed ID: 16954813
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
    Lin KY; Hung CC
    AIDS; 2015 Oct; 29(16):2213-4. PubMed ID: 26544585
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib.
    Erdélyi P; Fodor T; Varga AK; Czugler M; Gere A; Fischer J
    Bioorg Med Chem; 2008 May; 16(9):5322-30. PubMed ID: 18353655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
    Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.